Fascism on the internet
The US seizure of domain names on the web is ostensibly a crackdown on online piracy but it could end up as censorship
Public domain is not elementary, Sherlock
The Sherlock Holmes case highlights the stranglehold of copyright laws in the US
The innovation WHO needs
The strategy to push public health, innovation and intellectual property is a tough challenge because of funding constraints
Trademarks, jai ho!
Songs have been the subject of copyright and trademark battles. In India composer A R Rahman is holding up a film for using his song Jai Ho as …
The NATCO CL fallout
The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market
FARM IP, ENTER WIPO
Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO
Brickbats for compulsory licences
US criticises India and BRIC group for strengthening provisions on life-saving medicines
Spy versus spy and high tech gizmos
From secure manhole covers to Internet tracking systems, NSA has an arsenal of patents
How to save $25 billion and more on drug costs
Patent settlements bring cheaper generics to market early and cut healthcare spending
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Biodiversity—India’s other scandal
CAG slams the national biodiversity authority for allowing questionable patents
Japanese biopiracy of our Ballia barley
Japan’s Sapporo brewery patents Indian barley gene without giving benefit to farmers
Left sees red over Marx copyright
A small publisher of Collected Works has run afoul of Marxists by asserting copyright
Rotten tomato for Monsanto
US biotech giant's claim on a natural tomato is its latest patent to be revoked by Europe after soy and wheat
Crazy for GI? Think again
The protection of Geographical Indication is not a guarantee that the artisan or producer will benefit; traders can corner the premium
A rather ridiculous gap
Clothing giant Gap’s trademark infringement notice to an NGO selling products made from recycled waste is a curious case
India’s 3 D Message
The Supreme Court judgment in the Novartis case clearly upholds India’s patent laws, not weakens the patent regime
The fine line for judges
Judges have recused themselves in a number of cases but there are no clear guidelines on what constitutes conflict of interest
Pushing limits of drug access
Relying solely on gross national income to determine priorities in global health is not working any more
NCD battle starts now
The UN agreement on non-communicable diseases will get snagged on the issue of intellectual property rights for drugs
Bitter ABS medicine for AYUSH
Manufacturers cry foul as they receive notices from state boards to pay royalty
Maths of Gilead's hepatitis C drug
Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price
Obama takes first dip
The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative
Access, yes. Sharing, no
The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources